At this year’s 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, more than 40,000 people from around the world (including 25,000 oncology professionals) convened to discuss the latest advances in oncology. As we practicing clinicians know, progress in medicine is made in small steps. Success is sometimes measured by extending patient survival rates by mere months. With that in mind, this year’s ASCO meeting highlighted our continued progress in cancer care.
This issue of Oncology & Biotech News
presents some of the most noteworthy and newsworthy information from the meeting. The conference’s theme, “Translating Research into Practice,” is an important one for practicing oncologists. The abundance of ongoing cancer-related research was evident in the more than 4,000 abstracts presented at this year’s meeting. They represent a preview of future medical breakthroughs and, hopefully, opportunities to help improve patients’ lives.
Our objective is to provide timely, relevant information for the practicing oncologist with the goal of enhancing patient care. We hope that this ASCO coverage helps in that goal. Please look through the pages of this issue to find significant news from the meeting as well as updates on ongoing clinical trials—research and data that assist you in your daily practice.
We’d like to hear from you. Does Oncology & Biotech News
provide you with the most current and critical information on issues of importance to you? Is our special coverage of ASCO particularly timely and useful? Please let us know, so that we can tailor our reporting to best meet your needs.